Skip to main content

Table 10 Differential discounting results for CVD risk without and with diabetes for four risk levels. All dominated strategies have been excluded

From: Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study

 

Base case

Lower DR

No DR

 

Base case

Lower DR

No DR

Strategy

oDR - 3 %

oDR - 1.5 %

oDR - 0 %

Strategy

oDR - 3 %

oDR - 1.5 %

oDR - 0 %

CVD risk

       

  Low risk

ICER

Moderate risk

ICER

  No treatment

   

No treatment

   

  ACEI_Diu

1327

907

585

ACEI_Diu

164

118

082

  ACEI_Diu_Sta

3175

2121

1497

ACEI_Diu_Sta

554

379

262

  High risk

   

Very high risk

   

  No treatment

   

No treatment

   

  ACEI_CCB_Diu

349

252

176

ACEI_CCB_Diu_ASA

498

364

258

  ACEI_CCB_Diu_Sta

607

432

293

ACEI_CCB_Diu_Sta_ASA

652

461

315

CVD risk with diabetes

       

  Low risk

   

Moderate risk

   

  No treatment

   

No treatment

   

  Sulf_ACEI_CCB

608

465

311

Sulf_ACEI_CCB

115

083

058

  Big_Sulf_ACEI_CCB

958

645

430

Big_Sulf_ACEI_CCB

256

179

123

  Big_Sulf_ACEI_CCB_Sta

2480

1769

1126

Big_Sulf_ACEI_CCB_Sta

945

675

450

  High risk

   

Very high risk

   

  No treatment

   

No treatment

   

  Big_Sulf_ACEI_CCB

309

222

154

Big_Sulf_ACEI_CCB_ASA

350

258

184

  Big_Sulf_ACEI_CCB_Sta

914

640

436

Big Sulf ACEI CCB Sta ASA

704

505

346

  Big Sulf ACEI ARB CCB Sta

10300

7357

4905

Big Sulf ACEI ARB CCB Sta ASA

7615

4950

3536

  1. DR - Discount rate; ICER - Incremental cost-effectiveness ratio